24/7 Market News Snapshot 29 Jul 2024 – Cognition Therapeutics, Inc. Common Stock (NASDAQ: CGTX)

July 29, 2024

Press Release

DENVER, Colo., 29 July, 2024 (247marketnews.com) – (Nasdaq:CGTX) are discussed in this article.
Cognition Therapeutics, Inc. (CGTX) has garnered widespread attention with its stock price surging by an impressive 71.81% to $3.455 in the pre-market session, indicating a significant shift in market sentiment and heightened investor interest. The substantial trading volume of 1.7 million shares underscores the growing momentum behind Cognition Therapeutics, Inc., presenting potential investment opportunities in this innovative biopharmaceutical company.

In a groundbreaking development, Cognition Therapeutics, Inc. has announced encouraging results from the CT1812 treatment study, showcasing a substantial ~40% improvement in cognitive measures compared to the placebo. The study’s findings demonstrate consistent positive changes across various cognitive and functional parameters, highlighting the transformative potential of CT1812 in enhancing cognitive function. With a favorable safety profile and notable impact on Neurofilament Light Chain levels, a key marker of neurodegeneration, CT1812 emerges as a promising advancement in the realm of cognitive health.

Investors and stakeholders are invited to an exclusive webcast at 8:30 a.m. ET to delve into the study’s outcomes further. This event offers a unique opportunity to gain insights into the remarkable results of the CT1812 treatment study and its implications for the future of cognitive health. The success of the study underscores Cognition Therapeutics, Inc.’s dedication to pioneering solutions for cognitive disorders and signifies a significant breakthrough in addressing cognitive decline and neurological complications.

For comprehensive details on Cognition Therapeutics, Inc.’s latest advancements and the transformative potential of CT1812, please visit globenewswire.com.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 Market News, Inc Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.